News

GSK's asthma drug wins FDA approval to treat 'smoker's lung'
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...
Medical Dialogues1d
Blood eosinophil count tied to pseudomonas aeruginosa infection but not efficacy of inhaled tobramycin: Study
Bronchiectasis is a chronic airway suppurative disease in which recurrent airway infections, inflammation and remodeling have ...
The American Journal of Managed Care8h
FDA Approval of Mepolizumab Offers New Hope for Patients With Eosinophilic COPD: Gerard Criner, MD, FACP, FACCP
Gerard Criner, MD, FACP, FACCP, MATINEE investigator, highlights trial results that showed reduced exacerbations and delayed disease progression in patients with eosinophilic chronic obstructive ...
Healio3d
Lung function improves for patients with asthma within 24 hours with rademikibart
Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, ...
EurekAlert!4d
Blood eosinophil count is associated with pseudomonas aeruginosa infection but not the efficacy of inhaled tobramycin (Eur Respir J)
A published study has demonstrated that blood eosinophil counts (BECs) correlated with the disease severity, lung function, exacerbations in bronchiectasis. Multinational observational studies ...
Pharmaceutical Technology2d
ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients
An ATS 2025 session presented data showing that anti–IL-5 biologics significantly cut exacerbations in coexisting asthma and ...
GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...